M Campioni - Publications, H-index & Citations

M Campioni

Amgen

2H指数

27论文数

24被引数

收录论文 11

发表时间

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data

EUROPEAN JOURNAL OF HEALTH ECONOMICS

IF3

2019-10-31

OAAI

Campioni, M.; Agirrezabal, I.; Hajek, R.; Minarik, J.; Pour, L.; Spicka, I.; Gonzalez-McQuire, S.; Jandova, P.; Maisnar, V.

MODELING COVARIATE-ADJUSTED SURVIVAL FOR ECONOMIC EVALUATIONS IN ONCOLOGY

VALUE IN HEALTH

IF6

2017-10-01

OAAI

Majer, I. M.; Castaigne, J.; Palmer, S.; DeCosta, L.; Campioni, M.

LONG-TERM OUTCOMES AND TREATMENT PATTERNS IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA IN THE REAL-WORLD SETTING: A RETROSPECTIVE ANALYSIS OF THE CZECH RMG REGISTRY

VALUE IN HEALTH

IF6

2016-05-01

OAAI

Hajek, R.; Jarkovsky, J.; Campioni, M.; DeCosta, L.; Treur, M.; Gonzalez-McQuire, S.; Bouwmeester, W.

Chart Review Study to Evaluate Health Care Resource Utilization of Patients with Symptomatic Multiple Myeloma in the United Kingdom

VALUE IN HEALTH

IF6

2016-05-01

OAAI

Gonzalez-McQuire, S.; Yong, K.; Flinois, A.; Gazzola, C.; Schoen, P.; Campioni, M.; DeCosta, L.; Fink, L.

DEVELOPMENT OF A CONCEPTUAL MODEL OF MULTIPLE MYELOMA FOR USE IN ECONOMIC MODELLING: A SYSTEMATIC LITERATURE REVIEW TO IDENTIFY THE EVIDENCE BASE

VALUE IN HEALTH

IF6

2015-11-01

PREAI

Gonzalez-McQuire, S.; Campioni, M.; Bennison, C.; Xu, W.; Pantiri, K.; Hensen, M.; Weisel, K.; Terpos, E.; Knop, S.

BUDGET IMPACT ANALYSIS OF CARFILZOMIB FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA (MM) IN MEXICO

VALUE IN HEALTH

IF6

2015-11-01

OAAI

Alva, M. E.; Campioni, M.; Zamora, J.; Giannopoulou, A.

DEVELOPMENT AND VALIDATION OF A CONCEPTUAL MODEL OF MULTIPLE MYELOMA

VALUE IN HEALTH

IF6

2015-11-01

OAAI

Gonzalez-McQuire, S.; Campioni, M.; Bennison, C.; Xu, W.; Pantiri, K.; Hensen, M.; Weisel, K.; Terpos, E.; Knop, S.

COST EFFECTIVENESS OF ROMIPLOSTIM FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS IN THE CZECH REPUBLIC

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Brezina, T.; Klimes, J.; Dolezal, T.; Maskova, H.; Campioni, M.; Kutikova, L.

COST-EFFECTIVENESS OF ROMIPLOSTIM FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN PORTUGAL

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Augusto, M.; Gouveia, M.; Borges, M.; Campioni, M.

COST PER RESPONSE ANALYSIS FOR THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS), IN THE TREATMENT OF ADULT CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Alva, M. E.; Rivera, R.; Arocho, R.; Campos, I; Campioni, M.

Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen resistant prostate cancer cell line (PC3)

BONE

IF3.6

2006-03-01

PREAI

Santini, D; Vincenzi, B; Rosolowski, M; Altucci, L; Campioni, M; Loeffler, M; Caraglia, M; Baldi, A; Tonini, G

研究方向